The efficacy of traditional chinese medicine on Novel Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital: a prospective, randomized controlled trial
- Conditions
- novel coronavirus pneumonia (COVID-19)
- Registration Number
- ITMCTR2000003001
- Lead Sponsor
- China Academy of Chinese Medical Sciences; Zhongnan Hospital of Wuhan University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
(1) Comply with the diagnostic criteria for general type COVID-19 in the Diagnosis and Treatment Program for COVID-19(trial version 5th).
(2) Agree to participate in the study and the patient or legal guardian signs the informed consent form.
(1) Patients who can not guarantee compliance of using TCM during the treatment period, or patients who are difficult to take medicine by oral or nasal route.
(2) Patients who have been more than 7 days since definite diagnosis.
(3) Patients with severe primary respiratory disease or other pathogenic microbial pneumonia that needs to be identified with COVID-19.
(4) Maternal, or patients with a positive urine pregnancy test.
(5) Patients with other systemic malignant diseases such as malignant tumors, mental illnesses, etc., which the researchers consider unsuitable for participation in the study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of conversion to severe or critical illness;
- Secondary Outcome Measures
Name Time Method Blood routine test;Psychological outcomes;Chest imaging;Blood biochemical test;Rate of disisolation;TCM symptom;Body temperature;